Gene · 79001
Papers3,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic review and meta-analysis of AI accuracy in warfarin dose prediction across ethnic groups. | Eur J Clin Pharmacol | 2026 | 41553511 | PubTator, text mining | PubMed |
| Development of a comprehensive cardiovascular disease genetic risk assessment test. | Genet Med Open | 2026 | 41551008 | PubTator, text mining | PubMed |
| Narrative Review of Management Strategies and Risk Mitigation for Gastrointestinal Bleeding in Atrial Fibrillation Patients Receiving Warfarin. | Clin Appl Thromb Hemost | 2026 | 41525219 | PubTator, text mining | PubMed |
| Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next-Generation Sequencing for Routine Clinical Practice. | Clin Transl Sci | 2026 | 41456102 | PubTator, text mining | PubMed |
| Improving Genotype Imputation in High-Dimensional Pharmacogenomics Using Multiple Imputation: Evaluation with Machine Learning Approaches. | Clin Pharmacol Ther | 2026 | 41407383 | PubTator, text mining | PubMed |
| Clinical, genetic, and nutritional determinants of INR: role of plasma warfarin and hydroxylated metabolite levels in anticoagulated Mexican patients. | J Thromb Thrombolysis | 2026 | 41184691 | PubTator, text mining | PubMed |
| A comparison of anticoagulant activities of warfarin and its imino-derivatives: in silico molecular docking evaluation. | J Biomol Struct Dyn | 2026 | 40607850 | PubTator, text mining | PubMed |
| Clinically actionable genetic variation in patients with or at high-risk of cardiovascular diseases from the Montreal Heart Institute. | Pharmacogenomics | 2025 | 41524197 | PubTator, text mining | PubMed |
| Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca. | Med Pharm Rep | 2025 | 41496885 | PubTator, text mining | PubMed |
| Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Gene Polymorphisms Predict Arterial Stiffness and Serum MGP Levels in Chronic Kidney Disease Patients. | Genes (Basel) | 2025 | 41465069 | PubTator, text mining | PubMed |
| [Application of an interpretable neural network framework based on the LASSO-proj algorithm for warfarin dose prediction]. | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | 2025 | 41448766 | PubTator, text mining | PubMed |
| Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland. | Sci Rep | 2025 | 41298791 | PubTator, text mining | PubMed |
| Comprehensive Genome-Wide Analysis of Shared Genetic Factors in Gastrointestinal and Neurodegenerative Diseases. | Brain Behav | 2025 | 41277170 | PubTator, text mining | PubMed |
| The Clinical Pharmacogenetics Implementation Consortium's consensus-based framework for assigning allele function. | Am J Hum Genet | 2025 | 41175864 | PubTator, text mining | PubMed |
| The Genetic Polymorphisms of CYP2C9 and VKORC1 in the Saudi Population and Their Impact on Anticoagulant Management. | Medicina (Kaunas) | 2025 | 41155858 | PubTator, text mining | PubMed |
| Predictor Role of VKORC1 rs9923231, CYP4F2 rs2108622, and GGCX rs11676382 Polymorphisms of 5 Years Mortality of Patients with Acute Ischemic Stroke. | Medicina (Kaunas) | 2025 | 41155747 | PubTator, text mining | PubMed |
| Genome-wide screening of pharmacogenomic biomarkers in jordanian patients with genetic disorders. | Pharmacogenomics J | 2025 | 41109911 | PubTator, text mining | PubMed |
| SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients. | PLoS One | 2025 | 41056273 | PubTator, text mining | PubMed |
| Prevalence of risk phenotypes associated with CYP2C9*2, *3, and VKORC1 c.-1639G>A genetic polymorphisms in world populations: implications in clinical practice. | Front Pharmacol | 2025 | 41050406 | PubTator, text mining | PubMed |
| Genetic and epigenetic architectures of stroke: Insights from GWAS to precision medicine. | Neurochem Int | 2025 | 41005670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79001/papers?page=4